Since CHK1 and RAD51 are well-known players in homologous recombination and were also downregulated upon RHPS4 treatment, as previously reported in glioma cells [33]; we decided to evaluate their levels, in order to gain insight in the recombinational mechanism activated. Here, RAD51 is linked to central nervous system cancer.